STEVENAGE, England, April 10, 2012 - Novella Clinical, Inc., a full service contract research organization (CRO), today announced John Sulola has joined as business development director. Sulola is responsible for championing Novella’s clinical research and resourcing services with biopharmaceutical and medical device clients located in the United Kingdom and mainland Europe.
Sulola has a lengthy history of successful client relationship management within the biopharma and CRO industries having worked most recently as director of business development and marketing at Richmond Pharmacology, an early phase CRO. Sulola previously served in various business development and marketing roles of increasing responsibility at Covance, Quintiles and Eli Lilly.
“John’s seniority, network of contacts and understanding of both the biopharmaceutical and CRO environment will be highly valuable as we continue to expand our biopharmaceutical and medical device outsourcing solutions throughout Europe,” said Elizabeth Edwards, vice president, European operations for Novella Clinical.
Novella’s more than 800 global professionals provide a full range of clinical research outsourcing solutions as well as flexible resourcing models for oncology, medical device and biopharma companies. Currently supporting clients in 19 European countries, Novella continues to expand throughout the EU.
Sulola holds an MBA from Middlesex University, a master’s degree in biotechnology from Imperial College and a bachelor’s degree in biochemistry from Hull University.